Xarelto & Pradaxa Lawyer in Chicago
Leading Chicago Drug Injury Attorneys Accepting Cases Nationwide
Xarelto is one of the newest – and most dangerous – blood thinners, developed by Bayer and Johnson & Johnson. Xarelto (rivaroxaban) is used to prevent blood clots and strokes. Since its approval in 2011, Xarelto has earned billions in profits, while putting patients at risk of irreversible and life-threatening bleeding.
Xarelto is very similar to fellow blockbuster drug Pradaxa, which also causes irreversible bleeding. Xarelto and Pradaxa’s “one size fits all” dosing and easy-to-manage prescribing directions is the reason behind their great popularity.
10,000+ Cases Handled Since 1985 - Call (888) 444-9136
When it comes to drug injury litigation, few firms are as experienced as Pintas & Mullins Law Firm. Over the last 30 years, we built a reputation for effective, tenacious representation, providing every one of our clients’ with the best possible evidence, data, and expert witnesses.
We are currently handling both Xarelto and Pradaxa cases nationwide, partnering with top litigators in each state. This partnership means our clients get two powerhouse firms for the cost of one. Our clients have the best shot at securing their financial future and receiving the medical care they needed.
Our results speak for themselves: we’ve recovered $60+ million for clients in all 50 states.
Our Chicago dangerous drug lawyers are currently investigating cases of serious injury or death from Xarelto use. If you’ve suffered an internal or external bleeding event from Xarelto or Pradaxa, you’re not alone. Call our firm for a free consultation.
Unlike warfarin (the original blood thinner), if a patient on Xarelto suffers any type of bleed there is no antidote to reverse the drug’s effects and stop the bleeding. Patients must wait for Xarelto to clear their system so their blood can clot normally. If the drug does not clear in time, patients will likely suffer a fatal bleed out.
The likelihood of fatal bleeding is higher among patients with kidney disease.
Approved Based on Fraud
Big Pharma spent millions marketing Xarelto as a safe, effective, and superior blood thinner based on, what turned out to be, fraudulent data. Xarelto is overpriced, at about $3,000 per year, yet is no more effective than warfarin, which costs about $200 per year.
Neither doctors nor patients were fully informed of Xarelto’s life-threatening side effects. Thousands of doctors prescribed Xarelto to their patients genuinely believing the drug was safe and effective, unaware it was actually extraordinarily dangerous and deadly. Patients left their doctor’s office with a Xarelto prescription and no information on how to treat or prevent complications.
Every drug sold in the U.S. must be approved the by FDA based on clinical research proving the drug is safe and effective in humans. Xarelto’s approval process was rife with fraud, misconduct, and cover-ups compared to science fair projects.
The Xarelto research submitted to the FDA consisted of four separate studies known as the RECORD trials. The FDA found repeated and systemic fraud at the RECORD sites. At one site the agency found falsified data; at another, medical records had been discarded in bulk. Site after site, there was evidence of misconduct, fraud, and suspicious practices so egregious that the data was thrown out.
Ultimately the FDA determined the entire RECORD 4 study was unreliable, and the other three RECORD trials were not much better. Nearly half of the trial sites in RECORD 2 showed evidence of misconduct – including clear evidence of data falsification - and that data was thrown out.
Despite the repeated fraud, the FDA still approved Xarelto for public use, and never informed the public of the trial misconduct. These four RECORD trials can still be found in esteemed medical journals without any mention of fraud. This means our doctors, who look to these journals for insight and guidance, are basing their prescribing decisions on false data.
For more information about these fraudulent results and subsequent investigations, take a look at our blogs on the subject: “Xarelto Researchers Deceive Top Medical Journal” and “Drug Safety & Clinical Trial Fraud.”
How Our Chicago Dangerous Drug Lawyers Can Help
Thousands of lawsuits have been filed against Xarelto, and claims continue to file in throughout the country. These lawsuits claim that Bayer and Johnson & Johnson failed to warn doctors and patients of the dangers of uncontrollable, irreversible bleeding.
We are accepting Xarelto claims involving:
- Abdominal bleeding
- Brain hemorrhage
- Abnormal liver function
- Hemorrhage stroke
- Fatal bleed outs
Xarelto lawsuits are consolidated under a single court in the Eastern District of Louisiana in a structure known as Multi-District Litigation, or MDL. The MDL (No. 2592) allows a single judge to preside over the bulk of lawsuits involving the same subject (Xarelto) and defendant (Johnson & Johnson and Bayer), smoothing out the process for thousands of injured plaintiffs.
A mass tort regarding Xarelto is also established in Philadelphia. All told, 3,400 plaintiffs are filing suit against Xarelto manufacturers for the harm they’ve suffered. The first trials are expected to begin in February 2017.
The Pradaxa MDL recently resulted in a $650 million settlement for plaintiffs—this may bode well for Xarelto cases.
We provide free, confidential case reviews to victims and families nationwide. Our Chicago Xarelto attorneys never charge any fees out of pocket, and we only get paid if we win you a settlement or verdict. Contact us 24 hours a day—we look forward to helping you get the answers and justice you need.